Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration
Authors
Keywords
-
Journal
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume 12, Issue 10, Pages 1299-1313
Publisher
Informa Healthcare
Online
2012-08-07
DOI
10.1517/14712598.2012.707176
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intravitreal aflibercept injection for neovascular (wet) age-related macular degeneration
- (2012) Matthew Ohr et al. EXPERT OPINION ON PHARMACOTHERAPY
- The Expanding Role of Vascular Endothelial Growth Factor Inhibitors in Ophthalmology
- (2012) Michael W. Stewart MAYO CLINIC PROCEEDINGS
- Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
- (2012) Daniel F. Martin et al. OPHTHALMOLOGY
- Anti-VEGF Compounds in the Treatment of Neovascular Age Related Macular Degeneration
- (2011) C. Campa et al. CURRENT DRUG TARGETS
- Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Primary Endpoint Results of a Phase II Study of Vascular Endothelial Growth Factor Trap-Eye in Wet Age-related Macular Degeneration
- (2011) David M. Brown et al. OPHTHALMOLOGY
- Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-Related Macular Degeneration: PIER Study Year 2
- (2010) Prema Abraham et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Risks of Mortality, Myocardial Infarction, Bleeding, and Stroke Associated With Therapies for Age-Related Macular Degeneration
- (2010) Lesley H. Curtis ARCHIVES OF OPHTHALMOLOGY
- Plasma levels of vascular endothelial growth factor and pigment epithelium-derived factor before and after intravitreal injection of bevacizumab
- (2010) K. Matsuyama et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Retinal artery occlusion following intravitreal anti-VEGF therapy
- (2009) Therese von Hanno et al. ACTA OPHTHALMOLOGICA
- Safety Implications of Vascular Endothelial Growth Factor Blockade for Subjects Receiving Intravitreal Anti–Vascular Endothelial Growth Factor Therapies
- (2009) Karl Csaky et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials
- (2009) P Mitchell et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Low fluence rate photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration
- (2009) C. Costagliola et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Antivascular endothelial growth factor therapy for neovascular age-related macular degeneration
- (2009) Thomas A Ciulla et al. CURRENT OPINION IN OPHTHALMOLOGY
- Should Avastin be used to treat age-related macular degeneration in the NHS? – No
- (2009) N V Chong EYE
- Dicephalic parapagus conjoined twins: A rare second trimester sonographic diagnosis
- (2009) Ahmet Mete et al. JOURNAL OF CLINICAL ULTRASOUND
- Cerebrovascular Accidents in Ranibizumab
- (2009) Takashi Ueta et al. OPHTHALMOLOGY
- A Phase I Study of Intravitreal Vascular Endothelial Growth Factor Trap-Eye in Patients with Neovascular Age-Related Macular Degeneration
- (2009) Quan Dong Nguyen et al. OPHTHALMOLOGY
- CONCENTRATION OF CYTOKINES IN THE AQUEOUS HUMOR OF PATIENTS WITH NAIVE, RECURRENT AND REGRESSED CNV ASSOCIATED WITH AMD AFTER BEVACIZUMAB TREATMENT
- (2009) MI IN ROH et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Cardiovascular Risk and Antiangiogenic Therapy for Age-related Macular Degeneration
- (2009) José Tuñón et al. SURVEY OF OPHTHALMOLOGY
- Intraocular Pharmacokinetics of Bevacizumab After a Single Intravitreal Injection in Humans
- (2008) Tim U. Krohne et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Ranibizumab Combined With Verteporfin Photodynamic Therapy in Neovascular Age-related Macular Degeneration (FOCUS): Year 2 Results
- (2008) Andrew N. Antoszyk et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Bevacizumab immune complexes activate platelets and induce thrombosis in FCGR2A transgenic mice
- (2008) T. MEYER et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- VEGF Inhibition and Renal Thrombotic Microangiopathy
- (2008) Vera Eremina et al. NEW ENGLAND JOURNAL OF MEDICINE
- Blood pressure rise following angiogenesis inhibition by bevacizumab. A crucial role for microcirculation
- (2007) J.-J. Mourad et al. ANNALS OF ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now